Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis
Status:
Not yet recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effects of testosterone treatment on erectile
function, fatigue, depression, cognitive function, quality of life, urinary incontinence,
pain, and damage to neurons in male Multiple Sclerosis patients with low testosterone, using
questionnaires, blood samples and a rectal exam in volunteers 55 years and older.
Phase:
Phase 4
Details
Lead Sponsor:
Tulane University
Collaborators:
Antares Pharma Inc. Louisiana State University Health Sciences Center in New Orleans